Cerebras put to the test of the $1.5T AI CapEx: real technology, concentrated risks
The Cerebras bet (WSE-3, IPO pending) sums up the ambiguity of the cycle: a wafer-scale architecture superior in inference, but an order book focused on G42 and a sector CapEx whose first signs of excess are accumulating.
3 min ago 0 0
















